Type 1 Diabetes

Different types of maternal diabetes and obesity can have many effects on the offspring, including increasing risk for certain psychiatric disorders.

By Sheri Colberg, PhD
Glucagon is such an important hormone when it comes to blood glucose management in everyone—and it both impacts and is impacted by type 1 diabetes (T1D). A recent mini-review in Physiological Reports focused on altered glucagon responses brought up some interesting points that are worth discussing further.

Cardiovascular and renal disease burdens also occur in type 1 diabetes.

According to two new studies, researchers have seen tremendous progress in delaying the onset of type one diabetes and slowing down the disease's progression.

A recent longitudinal study examines diabetes type 1 and brain cognitive differences in children. 

Dasiglucagon is a glucagon analog stable in an aqueous formulation with FDA approval for severe hypoglycemia use. The target population is patients with diabetes who are six years of age and older, but how effective is it among other subgroups?

Major electrocardiogram abnormalities have been found in patients with type 2 diabetes. 

Analysis finds that for every increase of a BMI unit, there was a 5-15% excess risk of developing severe COVID-19. 

Patients with COVID-19 may be at risk for developing stress-related hyperglycemia, which in turn could increase diabetes risk.

A century after the discovery of insulin, new insulins, new devices, and other innovations may again change the future of treatment for type 1 diabetes.